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Abstract  
 
Background:  The  IFA  test  is  one  of  the  most usual  methods  for  detecting  anti-Toxoplasma 
antibodies, although it has not any unique standardization. It seems that the microscopic judg-
ment of results is an important confounder in IFA test. Therefore, we conducted the present study 
to clarify the role of microscopic observer, and other confounders on the test. 
Methods: Eighty sera were collected from patients suspicious to toxoplasmosis for detection IgG 
anti-T. gondii by this test. Samples were examined against different series of antigens, IgG anti-
human conjugates, and observers.  
Results: There were no significant differences between the two series of antigens and conjugates. 
For the observers groups the kappa coefficient of the test results in the experts group (0.97, 0.94-
1.00) were significantly higher than the less experienced observers (0.77, 0.68-0.87). 
Conclusion: We recommend the IFA test to be performed only in reference laboratories and by 
laboratory  technicians  that  have  enough  experience  for  this  test.  Otherwise,  we  suggest  the 
substitution of this test with other tests like ELISA for the diagnosis and epidemiological studies. 
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 Introduction 
 
oxoplasmosis  is  a  benign  disease  in 
immune-competent individuals while 
it may be serious and life threatening 
disease in congenitally infected infants and 
in  immunocompromised  patients.
  Clinical 
signs of toxoplasmosis are non-specific and 
are not sufficiently characteristic for a defi-
nite  diagnosis.  Diagnosis  of  toxoplasmosis 
in humans is made by biological, serological, 
histological, molecular methods, or by some 
combination  of  the  above.  The  diagnosis 
mostly based upon serological methods with 
the  detection  of  IgG  and  IgM  anti-
Toxoplasma antibodies. There are numerous 
serological  procedures  available  for  the 
detection  of  humoral  antibodies;  these  in-
clude the Sabin–Feldman dye test, the indi-
rect  fluorescent  antibody  assay  (IFA),  the 
direct agglutination test, the latex agglutina-
tion  test  (LAT),  the  enzyme-linked  immu-
nosorbent  assay  (ELISA),  the  immunosor-
bent agglutination assay test (ISAGA), and 
the  IgG  avidity  test.The  IFA,  ISAGA  and 
ELISA have been modified to detect immu-
noglobulin  M  (IgM)  antibodies,  which  are 
useful  in  assessing  the  acute  phase  of 
toxoplasmosis (1).  
The IFA test is one of the most usual meth-
ods for detecting anti-Toxoplasma antibodies. 
This test is safe, inexpensive, sensitive, and 
easy to carry out and safer to perform and 
more  economical  than  the  dye  test  (2). 
Disadvantages of IFA test are; a microscope 
with UV light is needed, specific fluorescent 
immunoglobulin is required for each species, 
finally  false-positive  titers  may  occur  in 
hosts with anti-nuclear antibodies (3). 
The main components in IFA test are antigen 
and conjugate. Antigens are usually prepared 
from  the  RH  strain  T.  gondii  tachyzoites 
intrapretoneally propagated in mice. Conju-
gates are mostly polyclonal anti-human anti-
bodies  conjugated  with  fluorescein 
isothiocyanate (FITC).  
IFA  test  does  not  have  any  unique 
standardization, although its procedure may 
become  standard  by  some  laboratories. 
Reading the results of IFA test is based on 
microscopic  observation  of  peripheral 
fluorescence  colored  the  T.  gondii  tachy-
zoites. Subsequently, the final serum dilution 
demonstrating a 1+ level of fluorescence is 
reported (4).  
It  seems  that  the  microscopic  judgment  of 
the results is an important confounder in IFA 
test. Probably  it  is the  main reason for the 
low  rate  agreement  of  the  toxoplasmosis 
IgG-IFA  test  between  test  results  of  our 
previously  studied  four  laboratories  (5). 
Therefore, we carried out the present study 
to clarify the role of microscopic observer, 
antigen, and conjugate confounders. 
 
Materials and Methods 
 
Sera samples 
Eighty  sera  were  collected  from  patients 
suspicious  to  toxoplasmosis  admitted  to 
Nour, private laboratory in Tehran, Iran. The 
sera then were stored at -20°C. 
 
Parasite 
RH strain of T. gondii tachyzoites was pre-
pared  from  the  Dept.  of  Parasitology  and 
Mycology, School of Public Health, Tehran 
University of Medical Sciences, Iran.     
 
Antigens 
Antigens  were  prepared  according  to  our 
routine  procedure  in  the  Laboratory  of 
Toxoplasma Serology as follows (6). Briefly, 
tachyzoites were propagated in mice perito-
neum,  and  then  harvested  3  days  post 
inoculation. The organisms were then fixed 
with 1% formalin, and washed 3 times with 
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phosphate buffered saline (PBS, 0.15M, pH 
7.4). Finally, suspensions containing 50-100 
tachyzoites per high power field (400×) were 
coated  on  microscopic  slides.  Each  slides 
contained 12 discrete reaction sites. Antigen 
droplets were then air-dried and stored at -
20°C.  Two series of antigens were prepared 
entitled  A  antigen  and  B  antigen.  Tachy-
zoites of Ag B differed in 3 intraperitoneal 
passages in mice with Ag B.  
 
Anti-human IgG /FITC conjugates 
Two commercial anti-human IgG antibodies 
conjugated with FITC purchased including; 
I) polyclonal rabbit anti-human IgG antibody 
(DAKO, Denmark) and II) polyclonal goat 
anti- human IgG antibody (H and  L chains, 
Jackson,  Immuno-Research  Laboratories, 
INC, USA) named DAKO and JIRL, respec-
tively.  
 
Observers 
Four subjects including two experts (named 
A and B) and two low experts (named C and 
D) were participated in this study. The ex-
perts had at least 20 years of experience in 
IFA  toxoplasmosis  testing  and  low  experts 
were  PhD  students  whom  had  passed  the 
relevant training courses. 
 
IFA test procedure 
The IFA test was done according to routine 
procedure of our laboratory as described al-
ready (4). Toxoplasma gondii antigen slides 
were removed from the freezer and allowed 
to equilibrate to the room temperature. Sera 
(negative control, positive control, and tests) 
were diluted with PBS in 1:10 dilution and 
in  serial,  two  fold  dilutions  beginning  at 
1:100. Then, 10 µL of diluted controls and 
tests sera were added to the antigens. Slides 
were placed in a moist chamber, incubated at 
room  temperature  for  30  min,  and  then 
rinsed 3 times in a staining dish containing 
PBS.  Ten  microliters  working  dilutions  of 
anti-human  conjugates  (as  specified  by 
manufacturer)  were  added to  each  reaction 
sites on the slides. The slides were then incu-
bated, rinsed as described above and cover 
slips were mounted with  buffered glycerol. 
The slides were examined in the dark with a 
Leitz  (Dialux)  fluorescence  microscope 
equipped  with  a  Phillips  CS200  W-4  mer-
cury Lamp.             
Three series of tests with the following ar-
rangements performed: I) DAKO conjugate, 
observer A, and antigen A, II) JIRL conju-
gate, observer A, and antigen A, III) DAKO 
conjugate, antigen B, and observers A, B, C, 
and D.  
 
Statistical analysis  
The  kappa  coefficient  was  calculated  with 
95% confidence interval (CI) for IFA test at 
the selected cutoff by exact binominal meth-
ods. Similar results and those with only one 
titer difference compared with the results of 
two or more titer differences. 
 
 
Results 
 
Comparison of the conjugates 
The  results  of  the  first  and  second  series 
tests were the same in 31 cases (38.8%). But, 
37  of  cases  (46.2%)  showed  difference  in 
one titer, and 12 cases (15%) showed at least 
two titers difference .The kappa coefficient 
between this two series was 0.91 (CI: 0.87-
0.98).  The details of the results are shown in 
Table 1. 
 
Comparison of the antigens 
The results of the first and the third series 
tests  (reading  by  the  person  A)  were  the 
same in 43 cases (53.7%). However, 31 of 
cases (38.8%) showed difference in one titer, 
and 6 cases (7.5%) showed at least two titers 
difference.  The  kappa  coefficient  between 
this  two  series  was  0.85  (CI:  0.77-0.93).  Saraei  et al : Evaluation of Confounders in Toxoplasmosis … 
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The details of the results are showed in Ta-
ble 1 and 2. 
 
Comparison of the observers 
The result as reported by the experts and low 
experts is shown in Table 2, and as follows: 
 
A and B observers readings 
The results were the same in 60 (75%) of the 
cases. There was one titer difference  in 18 
cases  (22%),  and  at  least two titers  differ-
ence in two of the cases (2.5%), which one 
case  showed  two,  and  other  case  showed 
three titers difference. The kappa coefficient 
was 0.97 (CI: 0.94-1.00). 
 
A and C observers readings 
The results were the same in 47(58.8%) of 
the cases. There was one titer difference in 
23  cases  (28.8%),  and  at  least  two  titers 
difference in 10 of the cases (12.4%), which 
one case showed two, and other case showed 
three titers difference. The kappa coefficient 
was 0.87 (CI: 0.80-0.95). 
 
A and D observers readings 
The results were the same in 34 (42.5%) of 
the cases. There was one titer difference in 
27  cases  (33.8%),  and  at  least  two  titers 
difference in 19 of the cases (23.7%), which 
one case showed two, and other case showed 
three titers difference. The kappa coefficient 
was 0.76 (CI: 0.67-0.86). 
 
B and C observers readings 
The results were the same in 49 (61.3%) of 
the cases. There was one titer difference in 
20 cases (25%), and at least two titers differ-
ence in 11 of the cases (13.7%), which one 
case  showed  two,  and  other  case  showed 
three titers difference. The kappa coefficient 
was 0.86 (CI: 0.79-0.94). 
 
B and D observers readings 
The results were the same in 30 (37.5%) of 
the cases. There was one titer difference in 
31  cases  (38.8%),  and  at  least  two  titers 
difference in 19 of the cases (23.7%), which 
one case showed two, and other case showed 
three titers difference. The kappa coefficient 
was 0.76 (CI: 0.67-0.86). 
 
C and D observers readings 
The results were the same in 39 (48.7%) of 
the cases. There was one titer difference in 
23  cases  (28.8%),  and  at  least  two  titers 
difference in18 of the cases (22.5%), which 
one case showed two, and other case showed 
three titers difference. The kappa coefficient 
was 0.77 (CI: 0.68-0.87). 
 
By  excluding  the  sera  that  both  observers 
reported as negative, the  Kappa coefficient 
decreased  in  all  the  cases  (Table  3).  The 
common negative results for the pairs (A, B), 
(A, C), (A, D), (B, C), (B, D), and (C, D) 
were 40, 33, 20, 36, 21 and 20 respectively.
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Table 1: The results of toxoplasmosis IgG-IFA tests in the first and second series in the different 
conjugates 
 
  First series*  Second series ** 
Titer  N0.  %  N0.  % 
Negative(<1:10) 
1:10 
1:100 
1:200 
1:400 
1:800 
1:1600 
1:3200 
1:6400 
45 
13 
5 
5 
7 
0 
0 
4 
1 
56.3 
16.3 
6.3 
6.3 
8.8 
0 
0 
5 
1.3 
31 
18 
5 
8 
7 
3 
5 
1 
2 
38.8 
22.5 
6.3 
10 
8.8 
3.8 
6.3 
1.3 
2.5 
Total  80  100  80  100 
 
* First series = Antigen A, observer A and conjugate DAKO 
** Second series = Antigen A, observer A and conjugate JIRL 
 
 
Table 2: The results of toxoplasmosis IgG-IFA test in the third series (This series performed with 
Antigen B and conjugate DAKO) 
 
 
            A*                         B*                          C**                       D**  Observers  
Titer  N0.  %  N0.  %  N0.  %  N0.  % 
Negative(<1:10)  40  50  47  58.8  41  51.3  23  38.8 
1:10  14  17.5  6  7.5  16  20  24  30 
1:100  5  6.3  7  8.8  0  0  6  7.5 
1:200  6  7.5  6  7.5  9  11.3  7  8.8 
1:400  4  5  7  8.8  5  6.3  0  0 
1:800  5  6.3  1  1.3  3  3.8  3  3.8 
1:1600  1  1.3  2  2.5  6  7.5  11  13.8 
1:3200  1  1.3  1  1.3  0  0  6  7.5 
1:6400  4  5  3  3.8  0  0  0  0 
Total   80  100  80  100  80  100  80  100 
 
* A and B= Experts that have performed toxoplasmosis IFA tests for at least 20 years.  
**C and D= Low experts that were PhD parasitology students who had passed the relevant train-
ing courses of toxoplasmosis IFA tests. 
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Table 3: Kappa coefficients in the results of toxoplasmosis IgG-IFA tests 
 
Observers*  Kappa (95% CI)**  Kappa (95% CI)*** 
A&B 
A&C 
A&D 
B&C 
B&D 
C&D 
0.97 (0.94-1) 
0.87 (0.80-0.95) 
0.76 (0.67-0.86) 
0.86 (0.79-0.94) 
0.76 (0.67-0.86) 
0.77 (0.68-0.87) 
0.95 (0.88-1) 
0.79 (0.67-0.90) 
0.68 (0.56-0.80) 
0.75 (0.62-0.88) 
0.68 (0.56-0.80) 
0.70 (0.58-0.82) 
* A and B= Experts that have performed toxoplasmosis IFA tests for at least 20 years. C and D= 
Low experts that were PhD parasitology students who had passed the relevant training 
 ** With considering shared negative results in all sera 
*** Without considering shared negative results in all sera 
 
 
 
Discussion 
 
The  present  study  showed  that  the  micro-
scopic readings of IFA test are a main con-
founder  for  this  test.  For  that  reason,  in 
laboratories  in  which  this  test  is  the  only 
serological practice for the routine diagnosis 
of  toxoplasmosis,  the  results  may  be  re-
ported  falsely  positive  or  falsely  negative. 
False-positive results could lead to unneces-
sary  treatment  with  toxic  drugs  and  false-
negative  results  could  lead  to  a  lack  of 
necessary treatment.  
A criterion for microscopic diagnosis for the 
end point titer is the observation of a very 
tiny  band  of  yellow-green  fluorescence 
around  the  entire  cell  periphery  in  at  least 
50%  of  T.  gondii  tachyzoites  (11). 
Determination of this point is difficult, espe-
cially for low expert observers. It could be 
happen due to; (I) an incorrect diagnosis of 
fluorescent  around  the  tachyzoites,  (II) 
inevitable  differences  of  percentage  of  the 
counted tachyzoites marked with conjugates 
in  borderline  fields,  (III)  or  I  and  II 
simultaneously.  Therefore,  the  one  titer 
difference can be accepted since; the ratio of 
tachyzoites  showing  fluorescent  in  the 
microscopic fields may be different and sec-
ondly  ocular  error  in  determination  of 
borderline  fluorescent  is  usually  occurred. 
Evidently, in the present study there were 5-
6 differences in a number of end point titers 
between  expert  and  low  expert  observers 
with no obvious reason. 
Furthermore, our study showed that the abil-
ity  of  low  expert  observers  with  similar 
trainings,  also  have  important  differences 
among themselves in the reading of the test 
results.  This  is  partially  is  an  innate  diffi-
culty for the test which is observer depend-
ent  and  it  can  remarkably  declined  by 
increasing the experience of observers. 
In comparison of observers, by excluding the 
test  results  that  equally  reported  negative, 
the  kappa  coefficient  insignificantly  de-
creased  in  all  cases.  The  findings  showed 
that the main basis of the mistake in the IFA 
test  is  incorrect  diagnosis  of  fluorescent 
around the tachyzoites.                  
Our  study  also  showed  the  insignificant 
differences between the antigens and conju-
gates.  Conjugates  were  commercially  pur-
chased which according to regulations must 
be  evaluated  by  the  reference  laboratories 
before offering to market. Quality control of Iranian J Parasitol: Vol. 5, No.4, 2010, pp.55-62 
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the reagents for use in this test is very impor-
tant because this type of staining procedure 
is  extremely  sensitive  (4).  Antigens  were 
prepared  in  home  using  tachyzoites  of  T. 
gondii RH strain that have three intrapreto-
neal  passages  differences  from  each  other. 
Serial passages of tachyzoites in mice can be 
result  to  antigenic  variations,  although  the 
variations  will  not  change  IFA  test  results 
(7). 
IFA  test  can  be  also  used  for  seroepidem-
iological studies of T. gondii. Such studies 
have  a  particular  importance  for  decision-
making  in  public  health  for  T.  gondii 
infections. Remarkably, in recent years, the 
epidemiological  relationship  of  the  parasite 
with  the  chronic  brain  diseases  including 
schizophrenia (8), epilepsy (9) and migraine 
(10)  has  been  considered.  If  such  studies 
were conducted by low experts then the re-
sults might be misleading. Although, most of 
the epidemiological studies for T. gondii per-
form  by  ELISA  (11-13),  but  in  Iran,  most 
studies in this field have performed by IFA 
test (14-16).  
We recommend the IFA test to be performed 
only  in  the  reference  laboratories  and  by 
subjects that have enough experience for this 
test. Otherwise, we suggest the substitution 
of this test with other tests like ELISA, since 
the  test  not  only  has  no  preferences  than 
ELISA  test  but  also  has  many  significant 
disadvantages as proved by the present study.  
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